Genetics and biosafety

The Association of Clinical Neurophysiologists and Medical Geneticists of the Republic of Uzbekistan declares the necessity of establishing a national system for regulating the use of biological and genetic data from bioethical and legal perspectives.

We live in an era where genetic data have become a strategic resource. The implementation of personalized medicine, DNA diagnostics, digitalization of healthcare, and artificial intelligence creates new opportunities — but also introduces new risks.

International scientific grants and investments play an important role in the development of science and medicine, providing access to advanced technologies and global expertise. However, the export of biological materials outside the country, especially in large volumes, even when valuable diagnostic or scientific information is involved, is unacceptable. In the absence of clear legal and bioethical protection mechanisms, this contradicts the interests of national security, bioethics, and sovereignty.

In accordance with international legal standards:
• GDPR (European Union) requires genetic data to be regulated as highly sensitive data;
• The Council of Europe Convention on Human Rights and Biomedicine (Oviedo Convention) prohibits unethical use of biological data and discrimination;
• UNESCO recognizes genetic data as part of human dignity;
• The World Health Organization (2023) recommends that countries implement national control mechanisms for handling genetic data.

In particular, the large-scale export of biological materials and the transfer of genetic data outside the country — even within the framework of scientific grants — are inappropriate. This is not only a matter of security but also of fairness. All international scientific projects related to genetics and biobanking should be conducted exclusively within the territory of Uzbekistan, with the participation of national specialists and under the supervision of national institutions.

The Association emphasizes the priority of the rights of patients, physicians, and the state as the foundation of national biotechnological sovereignty.

We actively protect the interests of specialists and patients and strive to establish legal regulation in the fields of biosafety, genetic ethics, and personalized medicine.

We support the establishment of a National Genetic Laboratory operating exclusively within Uzbekistan, ensuring a full cycle—from the collection and storage of biological materials to their analysis and interpretation of genetic data—in strict compliance with international and national standards. Such a laboratory should be supported by the state and financed through mandatory health insurance systems and special national funds.

We support the creation of transparent conditions for participation in international scientific initiatives, ensuring the involvement of national specialists, legal protection of physicians and patients, and prevention of biological data leakage.

We participate in the development of regulatory legal acts, clinical protocols, and regulations in the fields of biosafety, genetic ethics, and legal frameworks.

The Association calls for the following measures at the state level:
• Develop and adopt a law on biosafety, bioethics, and protection of genetic data;
• Establish standards for storage, disposal, and cross-border transfer of biological materials;
• Create independent bioethical and legal committees for all projects involving genetic data;
• Conduct international research exclusively within the country and under national control;
• Introduce mandatory informed consent, transparent access to results, the right to refuse, and data deletion.

The Association of Clinical Neurophysiologists and Medical Geneticists of the Republic of Uzbekistan:
• Unites specialists in medical and laboratory genetics, clinical neurophysiology, neurology, neurosurgery, epileptology, pediatrics, and related disciplines;
• Protects the rights of the professional community and patients;
• Actively participates in shaping the scientific, ethical, and legal agenda in the field of medical technologies and genetic research;
• Contributes to scientific exchange, the implementation of innovative approaches, the development of personalized medicine, and ensuring national control over the country’s genetic resources.

info@acnemgu.uz
www.acnemgu.uz